申请人:Gershengorn Marvin C.
公开号:US20110195018A1
公开(公告)日:2011-08-11
Disclosed are oxo-hydroquinazolines that are useful as selective TSHR agonists. The compounds may be used for detecting or treating thyroid cancer, or treating a bone degenerative disorder.
揭示了作为选择性TSHR激动剂有用的羟基喹唑啉化合物。这些化合物可用于检测或治疗甲状腺癌,或治疗骨质退化性疾病。